ATE348892T1 - Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen - Google Patents

Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen

Info

Publication number
ATE348892T1
ATE348892T1 AT01931274T AT01931274T ATE348892T1 AT E348892 T1 ATE348892 T1 AT E348892T1 AT 01931274 T AT01931274 T AT 01931274T AT 01931274 T AT01931274 T AT 01931274T AT E348892 T1 ATE348892 T1 AT E348892T1
Authority
AT
Austria
Prior art keywords
protease
pneumoniae
chlamydia
strain
host
Prior art date
Application number
AT01931274T
Other languages
English (en)
Inventor
Andrew D Murdin
Raymond P Oomen
Joe Wang
Pamela Dunn
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Application granted granted Critical
Publication of ATE348892T1 publication Critical patent/ATE348892T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT01931274T 2000-05-08 2001-05-08 Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen ATE348892T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US20267200P 2000-05-08 2000-05-08
US20785200P 2000-05-30 2000-05-30
US21204400P 2000-06-16 2000-06-16
US21179700P 2000-06-16 2000-06-16
US21179600P 2000-06-16 2000-06-16
US21179800P 2000-06-16 2000-06-16
US21180100P 2000-06-16 2000-06-16
US23533500P 2000-09-26 2000-09-26
US23539800P 2000-09-26 2000-09-26
US23536100P 2000-09-26 2000-09-26

Publications (1)

Publication Number Publication Date
ATE348892T1 true ATE348892T1 (de) 2007-01-15

Family

ID=27581138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01931274T ATE348892T1 (de) 2000-05-08 2001-05-08 Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen

Country Status (6)

Country Link
EP (1) EP1282718B1 (de)
AT (1) ATE348892T1 (de)
AU (1) AU2001258105A1 (de)
CA (1) CA2408199A1 (de)
DE (1) DE60125350T2 (de)
WO (1) WO2001085972A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5366099A (en) 1998-08-20 2000-03-14 Connaught Laboratories Limited Nucleic acid molecules encoding inclusion membrane protein of (chlamydia)
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
EP1105489A1 (de) 1998-08-20 2001-06-13 Aventis Pasteur Limited Nukleinsäuren kodierend für pomp91a aus chlamydia
US6649370B1 (en) 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en) 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
CN100365120C (zh) 1998-12-08 2008-01-30 科里克萨有限公司 用于治疗及诊断衣原体感染的化合物和方法
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
JP2002541766A (ja) 1998-12-28 2002-12-10 アベンティス、パストゥール、リミテッド クラミジア抗原および対応するdna断片ならびにその使用
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
EP2172214A3 (de) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia-Antigene und entsprechende DNA-Fragmente sowie Verwendungen davon
WO2000066739A2 (en) 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2385325C (en) 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP1240331B1 (de) 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
AU2001255596A1 (en) 2000-04-21 2001-11-07 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
EP1282718B1 (de) 2000-05-08 2006-12-20 Sanofi Pasteur Limited Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
ATE440861T1 (de) 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US20030059896A1 (en) * 2000-12-21 2003-03-27 Shire Biochem Inc. Novel chlamydia antigens and corresponding DNA fragments
WO2010100632A2 (en) 2009-03-06 2010-09-10 Novartis Ag Chlamydia antigens

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010032336A (ko) * 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
EP1133572A4 (de) 1998-11-12 2005-06-15 Univ California Genomsequenz von chlamydia pneumoniae
CN100365120C (zh) 1998-12-08 2008-01-30 科里克萨有限公司 用于治疗及诊断衣原体感染的化合物和方法
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
WO2000066739A2 (en) 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2385325C (en) 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP1240331B1 (de) 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
AU2001255596A1 (en) 2000-04-21 2001-11-07 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
EP1282718B1 (de) 2000-05-08 2006-12-20 Sanofi Pasteur Limited Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
ATE440861T1 (de) 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae

Also Published As

Publication number Publication date
WO2001085972A3 (en) 2002-08-08
DE60125350T2 (de) 2007-07-12
AU2001258105A1 (en) 2001-11-20
EP1282718A2 (de) 2003-02-12
CA2408199A1 (en) 2001-11-15
WO2001085972A2 (en) 2001-11-15
DE60125350D1 (de) 2007-02-01
EP1282718B1 (de) 2006-12-20

Similar Documents

Publication Publication Date Title
DE60125350D1 (de) Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
WO2002018595A3 (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
WO1997033996A3 (en) Human bikunin
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2001074863A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
RS50435B (sr) Signalne sekvence za proizvodnju leu-hirudina pomoću sekrecija e.coli u medijumu kulture
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075114A3 (en) Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
DK1274853T3 (da) Materialer og fremgangsmåder, der angår immunreaktioner på fusionsproteiner
Bannantine et al. Development and use of a partial Mycobacterium avium subspecies paratuberculosis protein array
MXPA04004561A (es) Distribuidor de aire para sistema de biolixiviacion.
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
WO2001046226A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001092493A3 (en) 21956 and 25856, human aminopeptidases and uses thereof
EP1792995A3 (de) Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
WO2003031594A3 (en) Nucleotide and amino acid sequences relating to respiratory diseases and obesity
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2003029434A3 (en) Novel molecules of the hkid-1-related protein family and uses thereof
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2000026237A3 (en) Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
MXPA01001639A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2003020912A3 (en) Novel clark protein and nucleic acid molecules and uses therefor
ATE420106T1 (de) Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung
WO2001083523A3 (en) Stmst protein and nucleic acid molecules and uses therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties